Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation
- Citation:
- Seadawy, M. G., M. M. Lotfy, A. A. Saeed, and A. M. Ageez,
"Novel HER2-based multi-epitope vaccine (HER2-MEV) against HER2-positive breast cancer: In silico design and validation",
Human Immunology, vol. 85, no. 4: Elsevier, pp. 110832, 2024.
Abstract:
n/a
Notes:
n/a